noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

The eRulemaking Program

Proposed Settlement Agreement, Stipulation, Order, and Judgment, etc.:[...]
The eRulemaking Program

Accidental Release Prevention Requirements: Risk Management Programs[...]
The eRulemaking Program

Air Quality State Implementation Plans; Approvals and Promulgations:[...]

International News

Gemeinsamer Bundesausschuss

04/02/2026 | Press release | Distributed by Public on 04/02/2026 05:30

Arzneimittel-Richtlinie/Anlage VI: Agomelatin zur Behandlung der Fatigue bei postinfektiöser myalgischer Enzephalomyelitis/ Chronischem Fatigue-Syndrom (ME/CFS) und bei[...]

Beschluss

Arzneimittel-Richtlinie/Anlage VI:
Agomelatin zur Behandlung der Fatigue bei postinfektiöser myalgischer Enzephalomyelitis/ Chronischem Fatigue-Syndrom (ME/CFS) und bei Long/Post-COVID

Beschlussdatum: 02.04.2026
Inkrafttreten: noch nicht in Kraft

Richtlinie

Arzneimittel-Richtlinie

Richtlinien-Anlage

Anlage VI: Off-Label-Use

Zuständiger Unterausschuss

Arzneimittel

Pressemitteilung/Meldung

02.04.2026 | Pressemitteilung

Long/Post-COVID: Vier Wirkstoffe werden im Off-Label-Use verordnungsfähig

alle Pressemitteilungen

Gemeinsamer Bundesausschuss published this content on April 02, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 02, 2026 at 11:30 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]